A clinical approach to intrahepatic cholestasis of pregnancy

American Journal of Perinatology

Volumn 31, Issue 1, 2014, Pages 1-8

  Diken, Zaid ^a   Usta, Ihab M ^a   Nassar, Anwar H ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

diagnosis; epidemiology; etiology; intrahepatic cholestasis of pregnancy; management

Indexed keywords

ACTIVATED CARBON; BILE ACID; COLESTYRAMINE; DEXAMETHASONE; GUAR GUM; PHENOBARBITAL; S ADENOSYLMETHIONINE;

CLINICAL FEATURE; DELIVERY; DISEASE ASSOCIATION; FETAL WELL BEING; GESTATIONAL AGE; HUMAN; INTRAHEPATIC CHOLESTASIS; INTRAHEPATIC CHOLESTASIS OF PREGNANCY; MEDICAL DECISION MAKING; PATIENT COUNSELING; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PRURITUS; REVIEW;

CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS, INTRAHEPATIC; FEMALE; FETAL DEATH; FETAL DISTRESS; FETAL MONITORING; GESTATIONAL AGE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; URSODEOXYCHOLIC ACID;

EID: 84891824504     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0033-1333673     Document Type: Review

References (82)

1. Geenes V., Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol: 2009; 15 2049 2066
2. Riely C. A., Bacq Y. Intrahepatic cholestasis of pregnancy. Clin Liver Dis: 2004; 8 167 176
3. Lee R. H., Goodwin T. M., Greenspoon J., Incerpi M. The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol: 2006; 26 527 532
4. Laifer S. A., Stiller R. J., Siddiqui D. S., Dunston-Boone G., Whetham J. C. Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy. J Matern Fetal Med: 2001; 10 131 135
5. Reyes H. Review: intrahepatic cholestasis. A puzzling disorder of pregnancy. J Gastroenterol Hepatol: 1997; 12 211 216
6. Reyes H., Gonzalez M. C., Ribalta J., et al. Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Intern Med: 1978; 88 487 493
7. Reyes H. Sex hormones and bile acids in intrahepatic cholestasis of pregnancy. Hepatology: 2008; 47 376 379
8. Lammert F., Marschall H. U., Glantz A., Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol: 2000; 33 1012 1021
9. Rioseco A. J., Ivankovic M. B., Manzur A., et al. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol: 1994; 170 890 895
10. Koivurova S., Hartikainen A. L., Karinen L., et al. The course of pregnancy and delivery and the use of maternal healthcare services after standard IVF in Northern Finland 1990-1995. Hum Reprod: 2002; 17 2897 2903
11. Paternoster D. M., Fabris F., Palù G., et al. Intra-hepatic cholestasis of pregnancy in hepatitis C virus infection. Acta Obstet Gynecol Scand: 2002; 81 99 103
12. Goulis D. G., Walker I. A., de Swiet M., Redman C. W., Williamson C. Preeclampsia with abnormal liver function tests is associated with cholestasis in a subgroup of cases. Hypertens Pregnancy: 2004; 23 19 27
13. Heinonen S., Kirkinen P. Pregnancy outcome with intrahepatic cholestasis. Obstet Gynecol: 1999; 94 189 193
14. Williamson C., Hems L. M., Goulis D. G., et al. Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. BJOG: 2004; 111 676 681
15. Johnson P., Samsioe G., Gustafson A. Studies in cholestasis of pregnancy. I. Clinical aspects and liver function tests. Acta Obstet Gynecol Scand: 1975; 54 77 84
16. Pathak B., Sheibani L., Lee R. H. Cholestasis of pregnancy. Obstet Gynecol Clin North Am: 2010; 37 269 282
17. Brites D., Rodrigues C. M., van-Zeller H., Brito A., Silva R. Relevance of serum bile acid profile in the diagnosis of intrahepatic cholestasis of pregnancy in an high incidence area: Portugal. Eur J Obstet Gynecol Reprod Biol: 1998; 80 31 38
18. Reyes H., Báez M. E., González M. C., et al. Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile. J Hepatol: 2000; 32 542 549
19. Kauppila A., Korpela H., Mäkilä U. M., Yrjänheikki E. Low serum selenium concentration and glutathione peroxidase activity in intrahepatic cholestasis of pregnancy. Br Med J (Clin Res Ed): 1987; 294 150 152
20. Mays J. K. The active management of intrahepatic cholestasis of pregnancy. Curr Opin Obstet Gynecol: 2010; 22 100 103
21. Reyes H., Simon F. R. Intrahepatic cholestasis of pregnancy: an estrogen-related disease. Semin Liver Dis: 1993; 13 289 301
22. Meng L. J., Reyes H., Palma J., Hernandez I., Ribalta J., Sjövall J. Profiles of bile acids and progesterone metabolites in the urine and serum of women with intrahepatic cholestasis of pregnancy. J Hepatol: 1997; 27 346 357
23. Leevy C. B., Koneru B., Klein K. M. Recurrent familial prolonged intrahepatic cholestasis of pregnancy associated with chronic liver disease. Gastroenterology: 1997; 113 966 972
24. Müllenbach R., Bennett A., Tetlow N., et al. ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy. Gut: 2005; 54 829 834
25. Jacquemin E., Cresteil D., Manouvrier S., Boute O., Hadchouel M. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet: 1999; 353 210 211
26. Smith A. J., de Vree J. M., Ottenhoff R., Oude Elferink R. P., Schinkel A. H., Borst P. Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (-/-) mice. Hepatology: 1998; 28 530 536
27. Dixon P. H., Weerasekera N., Linton K. J., et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet: 2000; 9 1209 1217
28. Wasmuth H. E., Glantz A., Keppeler H., et al. Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene. Gut: 2007; 56 265 270
29. Eloranta M. L., Häkli T., Hiltunen M., Helisalmi S., Punnonen K., Heinonen S. Association of single nucleotide polymorphisms of the bile salt export pump gene with intrahepatic cholestasis of pregnancy. Scand J Gastroenterol: 2003; 38 648 652
30. Huang L., Zhao A., Lew J. L., et al. Farnesoid X receptor activates transcription of the phospholipid pump MDR3. J Biol Chem: 2003; 278 51085 51090
31. Savander M., Ropponen A., Avela K., et al. Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy. Gut: 2003; 52 1025 1029
32. Floreani A., Carderi I., Paternoster D., et al. Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy. Dig Liver Dis: 2008; 40 366 370
33. Kenyon A. P., Piercy C. N., Girling J., Williamson C., Tribe R. M., Shennan A. H. Obstetric cholestasis, outcome with active management: a series of 70 cases. BJOG: 2002; 109 282 288
34. Berg B., Helm G., Petersohn L., Tryding N. Cholestasis of pregnancy. Clinical and laboratory studies. Acta Obstet Gynecol Scand: 1986; 65 107 113
35. Kenyon A. P., Piercy C. N., Girling J., Williamson C., Tribe R. M., Shennan A. H. Pruritus may precede abnormal liver function tests in pregnant women with obstetric cholestasis: a longitudinal analysis. BJOG: 2001; 108 1190 1192
36. Reyes H., Radrigan M. E., Gonzalez M. C., et al. Steatorrhea in patients with intrahepatic cholestasis of pregnancy. Gastroenterology: 1987; 93 584 590
37. Huang W. M., Gowda M., Donnelly J. G. Bile acid ratio in diagnosis of intrahepatic cholestasis of pregnancy. Am J Perinatol: 2009; 26 291 294
38. Dann A. T., Kenyon A. P., Seed P. T., Poston L., Shennan A. H., Tribe R. M. Glutathione S-transferase and liver function in intrahepatic cholestasis of pregnancy and pruritus gravidarum. Hepatology: 2004; 40 1406 1414
39. Olsson R., Tysk C., Aldenborg F., Holm B. Prolonged postpartum course of intrahepatic cholestasis of pregnancy. Gastroenterology: 1993; 105 267 271
40. Alsulyman O. M., Ouzounian J. G., Ames-Castro M., Goodwin T. M. Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol: 1996; 175 4 Pt 1 957 960
41. Fisk N. M., Storey G. N. Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol: 1988; 95 1137 1143
42. Reid R., Ivey K. J., Rencoret R. H., Storey B. Fetal complications of obstetric cholestasis. BMJ: 1976; 1 870 872
43. Shaw D., Frohlich J., Wittmann B. A., Willms M. A prospective study of 18 patients with cholestasis of pregnancy. Am J Obstet Gynecol: 1982; 142 6 Pt 1 621 625
44. Vanjak D., Moreau R., Roche-Sicot J., Soulier A., Sicot C. Intrahepatic cholestasis of pregnancy and acute fatty liver of pregnancy. An unusual but favorable association? Gastroenterology: 1991; 100 1123 1125
45. Glantz A., Marschall H. U., Mattsson L. A. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology: 2004; 40 467 474
46. Rook M., Vargas J., Caughey A., Bacchetti P., Rosenthal P., Bull L. Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in a Northern California cohort. PLoS ONE: 2012; 7 e28343
47. Brites D. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid. Ann Hepatol: 2002; 1 20 28
48. Gorelik J., Shevchuk A., de Swiet M., Lab M., Korchev Y., Williamson C. Comparison of the arrhythmogenic effects of tauro- and glycoconjugates of cholic acid in an in vitro study of rat cardiomyocytes. BJOG: 2004; 111 867 870
49. Sheikh Abdul Kadir S. H., Miragoli M., Abu-Hayyeh S., et al. Bile acid-induced arrhythmia is mediated by muscarinic M2 receptors in neonatal rat cardiomyocytes. PLoS ONE: 2010; 5 e9689
50. Sepúlveda W. H., González C., Cruz M. A., Rudolph M. I. Vasoconstrictive effect of bile acids on isolated human placental chorionic veins. Eur J Obstet Gynecol Reprod Biol: 1991; 42 211 215
51. He M. M., Liu Z. F., Wang X. D. [Decreased volume of placental lobular villi vessels in patients with intrahepatic cholestasis of pregnancy]. Sichuan Da Xue Xue Bao Yi Xue Ban: 2011; 42 797 801
52. Zecca E., De Luca D., Barbato G., Marras M., Tiberi E., Romagnoli C. Predicting respiratory distress syndrome in neonates from mothers with intrahepatic cholestasis of pregnancy. Early Hum Dev: 2008; 84 337 341
53. Zecca E., De Luca D., Marras M., Caruso A., Bernardini T., Romagnoli C. Intrahepatic cholestasis of pregnancy and neonatal respiratory distress syndrome. Pediatrics: 2006; 117 1669 1672
54. Mazzella G., Rizzo N., Salzetta A., Iampieri R., Bovicelli L., Roda E. Management of intrahepatic cholestasis in pregnancy. Lancet: 1991; 338 1594 1595
55. Zapata R., Sandoval L., Palma J., et al. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience. Liver Int: 2005; 25 548 554
56. Mazzella G., Rizzo N., Azzaroli F., et al. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Hepatology: 2001; 33 504 8. Erratum in: Hepatology 2002 May;35(5):1291.
57. Chappell L. C., Gurung V., Seed P. T., Chambers J., Williamson C., Thornton J. G. PITCH Study Consortium Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ: 2012; 344 e3799
58. Bacq Y., Sentilhes L., Reyes H. B., et al. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis. Gastroenterology: 2012; 143 1492 1501 [Epub ahead of print]
59. European Association for the Study of the Liver EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol: 2009; 51 237 267
60. Paumgartner G., Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology: 2002; 36 525 531
61. Serrano M. A., Brites D., Larena M. G., et al. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta. J Hepatol: 1998; 28 829 839
62. Macias R. I., Pascual M. J., Bravo A., et al. Effect of maternal cholestasis on bile acid transfer across the rat placenta-maternal liver tandem. Hepatology: 2000; 31 975 983
63. Serrano M. A., Macias R. I., Vallejo M., et al. Effect of ursodeoxycholic acid on the impairment induced by maternal cholestasis in the rat placenta-maternal liver tandem excretory pathway. J Pharmacol Exp Ther: 2003; 305 515 524
64. Poupon R., Chrétien Y., Chazouillères O., Poupon R. E. Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis. J Hepatol: 2005; 42 418 419
65. Korkut E., Kisacik B., Akcan Y., Belenli O., Bicik Z., Yucel O. Two successive pregnancies after ursodeoxycholic acid therapy in a previously infertile woman with antimitochondrial antibody-negative primary biliary cirrhosis. Fertil Steril: 2005; 83 761 763
66. Brites D., Rodrigues C. M. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comments]. J Hepatol: 1998; 29 743 751
67. Azzaroli F., Turco L., Lisotti A., Calvanese C., Mazzella G. The pharmacological management of intrahepatic cholestasis of pregnancy. Curr Clin Pharmacol: 2011; 6 12 17
68. Hirvioja M. L., Tuimala R., Vuori J. The treatment of intrahepatic cholestasis of pregnancy by dexamethasone. Br J Obstet Gynaecol: 1992; 99 109 111
69. Glantz A., Marschall H. U., Lammert F., Mattsson L. A. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology: 2005; 42 1399 1405
70. Abbasi S., Hirsch D., Davis J., et al. Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome. Am J Obstet Gynecol: 2000; 182 1243 1249
71. Stramentinoli G., Di Padova C., Gualano M., Rovagnati P., Galli-Kienle M. Ethynylestradiol-induced impairment of bile secretion in the rat: protective effects of S-adenosyl-L-methionine and its implication in estrogen metabolism. Gastroenterology: 1981; 80 154 158
72. Ribalta J., Reyes H., Gonzalez M. C., et al. S-adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results. Hepatology: 1991; 13 1084 1089
73. Nicastri P. L., Diaferia A., Tartagni M., Loizzi P., Fanelli M. A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol: 1998; 105 1205 1207
74. Binder T., Salaj P., Zima T., Vítek L. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. J Perinat Med: 2006; 34 383 391
75. Warren J. E., Blaylock R. C., Silver R. M. Plasmapheresis for the treatment of intrahepatic cholestasis of pregnancy refractory to medical treatment. Am J Obstet Gynecol: 2005; 192 2088 2089
76. Londero F., San Marco L. Intrahepatic cholestasis of pregnancy: are we really able to predict fetal outcome? Am J Obstet Gynecol: 1997; 177 1274
77. Al Shobaili H. A., Hamed H. O., Al Robaee A., Alzolibani A. A., Amin A. F., Ahmad S. R. Obstetrical and fetal outcomes of a new management strategy in patients with intra-hepatic cholestasis of pregnancy. Arch Gynecol Obstet: 2011; 283 1219 1225
78. Roncaglia N., Arreghini A., Locatelli A., Bellini P., Andreotti C., Ghidini A. Obstetric cholestasis: outcome with active management. Eur J Obstet Gynecol Reprod Biol: 2002; 100 167 170
79. Lee R. H., Kwok K. M., Ingles S., et al. Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy. Am J Perinatol: 2008; 25 341 345
80. Obstetric Cholestasis RCOG Green-top Guideline No. 43, May 2011. Available at: http://www.rcog.org.uk/files/rcog-corp/GTG43obstetriccholestasis. pdf. Accessed October 15, 2012
81. Furhoff A. K. Itching in pregnancy. A 15-year follow-up study. Acta Med Scand: 1974; 196 403 410
82. Ropponen A., Sund R., Riikonen S., Ylikorkala O., Aittomäki K. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology: 2006; 43 723 728